Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-09 |
2024-03 |
-0.31 |
-0.26 |
0.05 |
16.13% |
2024-03-07 |
2023-12 |
-0.28 |
-0.42 |
-0.14 |
-50.00% |
2024-03-07 |
2023-12 |
-0.28 |
N/A |
N/A |
N/A |
2023-11-02 |
2023-09 |
-0.32 |
N/A |
N/A |
N/A |
2023-11-02 |
2023-09 |
-0.32 |
-0.26 |
0.06 |
18.75% |
2023-08-09 |
2023-06 |
-0.31 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-03 |
Raymond James |
Downgrade |
Strong Buy |
Outperform |
2023-05-10 |
Alliance Global Partners |
Upgrade |
|
Buy |
2023-05-10 |
TD Cowen |
Upgrade |
|
Outperform |
2023-03-20 |
Jefferies |
Downgrade |
Buy |
Equal-Weight |
2022-11-03 |
Raymond James |
Upgrade |
Outperform |
Strong Buy |
2022-03-06 |
Cowen & Co. |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2022-05-17 |
Dewan (Rashed Osman) |
Senior Officer of Issuer |
14.00K |
Acquisition or disposition in the public market |
2022-05-11 |
Ellacott Brian R |
Director of Issuer |
68.00K |
Acquisition or disposition in the public market |
2022-09-06 |
Knudson (Ken) |
Senior Officer of Issuer |
22.70K |
Acquisition or disposition in the public market |
2022-05-19 |
Lavoie (Cynthia Ph.D.) |
Director of Issuer |
6.00K |
Acquisition or disposition in the public market |
2022-05-19 |
Lortie (Murielle CPA) |
Director of Issuer |
3.15K |
Acquisition or disposition in the public market |
2022-05-23 |
Menawat (Arun Swarup Ph.D.) |
Director of Issuer |
412.30K |
Acquisition or disposition in the public market |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Gagnon Securities, LLC |
1.61M |
20.88M |
7.51% |
2023-06-29 |
FIL LTD |
1.20M |
15.62M |
5.62% |
2023-06-29 |
Letko, Brosseau & Associates Inc. |
1.17M |
15.20M |
5.47% |
2023-06-29 |
Timelo Investment Management Inc. |
731.66K |
9.52M |
3.42% |
2023-06-29 |
Gagnon Advisors, LLC |
679.30K |
8.84M |
3.18% |
2023-06-29 |
Raymond James Financial Services Advisors, Inc. |
581.24K |
7.56M |
2.72% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Royce Micro-Cap Fund |
227.30K |
2.96M |
1.06% |
2023-06-29 |
Royce Micro Cap Trust |
189.10K |
2.46M |
0.89% |
2023-06-29 |
Royce Capital Fund-Micro-Cap Portfolio |
97.50K |
1.27M |
0.46% |
2023-06-29 |
Pennsylvania Mutual Fund Inc |
52.10K |
677.79K |
0.24% |
2023-08-30 |
SPDR Portfolio Developed World ex-US ETF |
19.73K |
175.38K |
0.09% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
10.87K |
130.98K |
0.05% |
Split |
Date |
1 : 80 |
2015-02-09 |